Article Details

Selling US$2.0m worth of Immunovant, Inc. (NASDAQ:IMVT) stock at high prices would have ...

Retrieved on: 2022-10-01 14:31:38

Tags for this article:

Click the tags to see associated articles and topics

Selling US$2.0m worth of Immunovant, Inc. (NASDAQ:IMVT) stock at high prices would have .... View article details on HISWAI: https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-imvt/immunovant/news/selling-us20m-worth-of-immunovant-inc-nasdaqimvt-stock-at-hi

Excerpt

About NasdaqGS:IMVT. Immunovant. Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of ...

Article found on: simplywall.st

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up